Subscribe to Technical Bulletin
Tips
The remarkable process by which a single totipotent zygote develops into the approximately 37 trillion c
1
The remarkable process by which a single totipotent zygote develops into the approximately 37 trillion c
2

News News

  • [Weekly News] Genome-Wide CRISPR Screening: Uncovering New Host Factors to Optimize Rotavirus Vaccine Production

    LATEST DISCOVERY

    [Weekly News] Genome-Wide CRISPR Screening: Uncovering New Host Factors to Optimize Rotavirus Vaccine Production

  • [Weekly News] CRISPR Screening Revealing TMEM106B as a Mediator of an ACE2-Independent Infection Pathway for SARS-CoV-2

    LATEST DISCOVERY

    [Weekly News] CRISPR Screening Revealing TMEM106B as a Mediator of an ACE2-Independent Infection Pathway for SARS-CoV-2

  • [Weekly News] CRISPR/Cas9 Screening Unlocks Secrets of Stem Cell Power

    LATEST DISCOVERY

    [Weekly News] CRISPR/Cas9 Screening Unlocks Secrets of Stem Cell Power

  • [Research frontier] CRISPR Detection Trends

    LATEST DISCOVERY

    [Research frontier] CRISPR Detection Trends

  • [Weekly News] CRISPR-Cas9 Screening Shines: A More Sensitive and Specific Method to Identify Fetal Hemoglobin Inducers

    LATEST DISCOVERY

    [Weekly News] CRISPR-Cas9 Screening Shines: A More Sensitive and Specific Method to Identify Fetal Hemoglobin Inducers

  • [Weekly News] A Novel type VII CRISPR-Cas system: Discover the Potential of CRISPR Gene Editing

    LATEST DISCOVERY

    [Weekly News] A Novel type VII CRISPR-Cas system: Discover the Potential of CRISPR Gene Editing

  • [Weekly News] Deadly Link Between Industrial Pollutants and Fatty Liver: CRISPR Screening Reveals the Answer

    LATEST DISCOVERY

    [Weekly News] Deadly Link Between Industrial Pollutants and Fatty Liver: CRISPR Screening Reveals the Answer

  • [Weekly News] New Breakthrough in Cas Enzyme Structure: The First Structure of Type I-C NlaCas3 Enzyme Revealed!

    LATEST DISCOVERY

    [Weekly News] New Breakthrough in Cas Enzyme Structure: The First Structure of Type I-C NlaCas3 Enzyme Revealed!

  • [Weekly News] CRISPR-Cas9 Screening Technology Breaks Through the Limitations of Functional Genomic Screening in 2D Cell

    LATEST DISCOVERY

    [Weekly News] CRISPR-Cas9 Screening Technology Breaks Through the Limitations of Functional Genomic Screening in 2D Cell

  • [Weekly News] CRISPR screening reveals new mechanism: IL-4 contributes to CD8+ CART cell failure

    LATEST DISCOVERY

    [Weekly News] CRISPR screening reveals new mechanism: IL-4 contributes to CD8+ CART cell failure

  • [Weekly News] CRISPRa and Single-Cell RNA Sequencing Uncover Unique Regulatory Patterns Between Cell Types

    LATEST DISCOVERY

    [Weekly News] CRISPRa and Single-Cell RNA Sequencing Uncover Unique Regulatory Patterns Between Cell Types

  • [Weekly News] Fight Aging! CRISPR/Cas9 Reveals New Role of Glucose Metabolism in Cellular Senescence

    LATEST DISCOVERY

    [Weekly News] Fight Aging! CRISPR/Cas9 Reveals New Role of Glucose Metabolism in Cellular Senescence

  • [Weekly News] Breakthrough gRNA Algorithm Supercharges CRISPR Detection Sensitivity

    LATEST DISCOVERY

    [Weekly News] Breakthrough gRNA Algorithm Supercharges CRISPR Detection Sensitivity

EDGENE

Contact US

web logo
Kathy
Tel: info@editxor.com
Tel: 833-2263234
(USA Toll-free)
Tel: +1-224-345-1927
(USA)
Tel: +86-19120102676
(Intl)
✖ service online
✖